BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 82 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $214,000 | -73.2% | 56,821 | -67.3% | 0.01% | -76.2% |
Q4 2020 | $799,000 | -28.1% | 173,683 | +65.8% | 0.02% | -55.3% |
Q2 2020 | $1,112,000 | +108.2% | 104,782 | -11.6% | 0.05% | +74.1% |
Q1 2020 | $534,000 | +330.6% | 118,533 | +307.7% | 0.03% | +440.0% |
Q4 2019 | $124,000 | -10.1% | 29,077 | -21.3% | 0.01% | -28.6% |
Q3 2019 | $138,000 | – | 36,961 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABNER HERRMAN & BROCK LLC | 241,500 | $1,093,000 | 0.17% |
OCCUDO QUANTITATIVE STRATEGIES LP | 90,584 | $410,000 | 0.13% |
EPIQ PARTNERS, LLC | 10,550 | $48,000 | 0.03% |
Phoenix Holdings Ltd. | 173,683 | $799,000 | 0.02% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 5,500 | $25,000 | 0.02% |
CFO4Life Group, LLC | 12,003 | $54,000 | 0.02% |
HighPoint Advisor Group LLC | 15,733 | $115,000 | 0.01% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 357,761 | $1,619,000 | 0.01% |
Virtu Financial LLC | 24,484 | $111,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 93,902 | $435,000 | 0.01% |